| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |